Trial Profile
Effects of Manidipine Plus Rosuvastatin Versus Olmesartan Plus Rosuvastatin on Markers of Insulin Resistance in Patients With Impaired Fasting Glucose, Hypertension, and Mixed Dyslipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2013
Price :
$35
*
At a glance
- Drugs Manidipine (Primary) ; Rosuvastatin (Primary) ; Olmesartan medoxomil
- Indications Dyslipidaemias; Glucose intolerance; Hypertension
- Focus Pharmacodynamics
- 14 Aug 2013 New trial record